PPH News and Press, VanEck Vectors Pharmaceutical ETF From 04/04/24

2024-04-04 02:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-03 07:19:01 ET More on VanEck Vectors Pharmaceutical ETF PPH: Ignore The Election Scare, Buy Pharma And Healthcare Healthcare In 2024: Navigating The Biopharma Bull Run Healthcare dealmakers see increased M&A, valuations in 2024: KPMG Seeking Alph...

2024-04-01 13:18:45 ET More on VanEck Vectors Pharmaceutical ETF PPH: Ignore The Election Scare, Buy Pharma And Healthcare Healthcare In 2024: Navigating The Biopharma Bull Run Healthcare dealmakers see increased M&A, valuations in 2024: KPMG Seeking Alph...

2024-03-26 11:45:41 ET More on Consumer Discretionary Select Sector SPDR ETF, SPDR S&P Retail ETF, etc. Read the full article on Seeking Alpha For further details see: Cons Disc distribution & retail has the highest dispersion among S&P groups - MS

2024-03-22 11:15:00 ET Summary A positive January for U.S. stocks is typically a prelude to a positive year, with our analysis finding the correlation to hold 80% of the time since 1928. Stocks look well-positioned to outperform bonds and cash again this year, but high valuations ...

2024-03-19 02:50:00 ET Summary Typically, a back-up in rates has led to a sell-off in stocks. We believe the current environment is different for three reasons: the degree of the move in rates, current economic cycle, and strength of mega-cap technology. In this environment, we wo...

2024-03-14 23:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-13 10:10:00 ET Summary Jeff Hirsch, editor-in-chief of The Stock Trader’s Almanac, and Carter Worth, CEO and founder of Worth Charting, discuss their outlook for 2024 with MoneyShow's Mike Larson. Jeff expects a strong year for stocks, with gains of 8-15% broadly sp...

2024-03-09 03:59:00 ET Summary Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stocks could be ready for a healthy recovery. Biot...

2024-03-07 13:43:42 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Top ETFs to buy offer a smart solution for those looking to diversify their portfolios without the hassle. In the investment realm, diversification remains a key aspect of a sound investment st...